Nav Close

Amal Therapeutics SA, a spin-off from the University of Geneva, is developing new cancer vaccines, using with a proprietary family of vectors.

News

28.06.2022 Three startups in the spotlight (startupticker.ch)
25.09.2020 Recognition for Swiss innovation (startupticker.ch)
03.08.2020 Female entrepreneurs in the spotlight (startupticker.ch)
14.09.2016 Top 100 Swiss startups have been revealed (startupticker.ch)
24.03.2016 Amal Therapeutics receives CTI grant (startupticker.ch)
29.06.2015 Amal achieves proof of concept (startupticker.ch)
17.04.2015 Nine hot start-ups, 400 visitors and Joe Jimenez (startupticker.ch)

Milestones/News